Relevant units and personnel:
The 4th Chinese Medical Devices Risk Management Forum will be held in Suzhou from April 25 to 26, 2017 by the Center for Drug Reevaluation (CDR) of China Food and Drug Administration (CFDA) and China Association for Medical Devices Industry (CAMDI) so as to enhance the cooperation and communication between manufacturing enterprises, medical institutions and supervisory departments, improve the risk management for medical device products and find the risk rules during the clinical application of medical device products. The relevant matters are hereby notified as follows:
I. Conference theme
Innovation and progress of medical devices risk management
II. Organization units
(I) Sponsors:
CFDA Center for Drug Reevaluation
China Association for Medical Devices Industry
(II) Co-organizers:
Medtronic (Shanghai) Management Co., Ltd.
Johnson & Johnson Medical (China) Ltd.
Lifetech Scientific (Shenzhen) Co., Ltd.
Boston Scientific (Shanghai) Corporation
Flon Holding Group Co., Ltd.
Guanhao Biotech Co., Ltd.
Suzhou Inno-Mind Medical Innovation Service Co., Ltd.
III. Contents (Specific schedules are subject to recent further notice)
Main venue: Innovation and progress of medical devices risk management
The first branch venue: Application of medical device products and failure risk analysis
The second branch venue: Design of medical device products and risk control technology
The third branch venue: Medical device administration and risk evaluation
IV. Participants
Directors or of directors-in-charge of medical institutions at different levels, responsible personnel of departments of medical devices, specialists for clinical use, doctors, technologists and engineers; responsible personnel of medical device production and operation enterprises; specialists from scientific research institutions and colleges and universities; relevant personnel of medical device regulatory authorities.
V. Time and place
Time: April 25-26, 2017
Place: Suzhou Jinke Grand Hotel (1969, Binhe Rd, High-tech Zone, Suzhou City)
Industrial News:
Officers-in-charge: the review authorities for medical devices shall not be overcentralized so as to prevent and control the risk prevention and control administrative corruption.
The 4th Chinese Medical Devices Risk Management Forum will be held in Suzhou from April 25 to 26, 2017 by the Center for Drug Reevaluation (CDR) of China Food and Drug Administration (CFDA) and China Association for Medical Devices Industry (CAMDI) so as to enhance the cooperation and communication between manufacturing enterprises, medical institutions and supervisory departments, improve the risk management for medical device products and find the risk rules during the clinical application of medical device products. The relevant matters are hereby notified as follows:
I. Conference theme
Innovation and progress of medical devices risk management
II. Organization units
(I) Sponsors:
CFDA Center for Drug Reevaluation
China Association for Medical Devices Industry
(II) Co-organizers:
Medtronic (Shanghai) Management Co., Ltd.
Johnson & Johnson Medical (China) Ltd.
Lifetech Scientific (Shenzhen) Co., Ltd.
Boston Scientific (Shanghai) Corporation
Flon Holding Group Co., Ltd.
Guanhao Biotech Co., Ltd.
Suzhou Inno-Mind Medical Innovation Service Co., Ltd.
III. Contents (Specific schedules are subject to recent further notice)
Main venue: Innovation and progress of medical devices risk management
The first branch venue: Application of medical device products and failure risk analysis
The second branch venue: Design of medical device products and risk control technology
The third branch venue: Medical device administration and risk evaluation
IV. Participants
Directors or of directors-in-charge of medical institutions at different levels, responsible personnel of departments of medical devices, specialists for clinical use, doctors, technologists and engineers; responsible personnel of medical device production and operation enterprises; specialists from scientific research institutions and colleges and universities; relevant personnel of medical device regulatory authorities.
V. Time and place
Time: April 25-26, 2017
Place: Suzhou Jinke Grand Hotel (1969, Binhe Rd, High-tech Zone, Suzhou City)
Industrial News:
Officers-in-charge: the review authorities for medical devices shall not be overcentralized so as to prevent and control the risk prevention and control administrative corruption.